Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community

Table 5

Follow-up trends among practitioners in North America and the global community.

Variable	North America, (%)	Global community, (%)	value
Follow-up of patients with acute saphenous thrombophlebitis			<0.005
<1 week	142 (38.9%)	21 (17.2%)
1–4 weeks	102 (28.0%)	24 (19.7%)
1–3 months	30 (8.2%)	15 (12.3%)
Only if symptoms worsen	25 (6.9%)	25 (20.5%)
Other/no answer	66 (18.1%)	37 (30.3%)
Follow-up for patients with SVT of superficial tributaries/varicosities besides saphenous vein			0.27
<1 week	72 (19.7%)	26 (21.3%)
1–4 weeks	64 (17.5%)	20 (16.4%)
1–3 months	51 (14.0%)	21 (17.2%)
Only if symptoms worsen	54 (14.8%)	22 (18.0%)
Other/no answer	124 (34.0%)	33 (27.1%)
Treating patients with SVT after successful GSV ablation			<0.005
Compression and NSAIDs	225 (61.6%)	39 (32.0%)
Immediate clot drainage	98 (26.9%)	36 (29.5%)
Other/no answer	42 (11.5%)	47 (38.5%)
Initially treating patients with trapped blood after sclerotherapy			<0.005
Compression and NSAIDs	123 (33.7%)	37 (30.3%)
Immediate clot drainage	198 (54.3%)	42 (34.4%)
Other/no answer	43 (12.1%)	43 (35.3%)